世界の人乳オリゴ糖市場見通し2018-2027

Stratistics MRCが発行した調査報告書(SMRC20FB018)
◆英語タイトル:Human Milk Oligosaccharides - Global Market Outlook (2018-2027)
◆商品コード:SMRC20FB018
◆発行会社(リサーチ会社):Stratistics MRC
◆発行日:2020年1月
◆ページ数:138
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:食品
◆販売価格オプション(消費税別)
Single UserUSD4,150 ⇒換算¥456,500見積依頼/購入/質問フォーム
Five UserUSD5,250 ⇒換算¥577,500見積依頼/購入/質問フォーム
Global Site LicenseUSD7,500 ⇒換算¥825,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はStratistics MRC社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。Stratistics MRC社の概要及び新刊レポートはこちらでご確認いただけます。

Stratistics MRCは世界の人乳オリゴ糖市場が2018年1790万ドルから2027年9805万ドルまで年平均21%成長すると予測しています。当資料では、人乳オリゴ糖について調査を行い、エグゼクティブサマリー、序論、市場トレンド分析、ファイブフォース分析、製品別(シアリルラクトース(6’SL)、シアリルラクトース(3’SL)、ラクト-N-テトラオース(LNT)、ラクト-N-ネオテトラオース(LNnT)、フコシルラクトース(3’FL))分析、用途別(機能性食品および飲料、栄養補助食品、幼児用フォーミュラ、人間と動物の健康成分、その他)分析、地域別分析、主要動向、企業概要に区分し掲載しています。
・エグゼクティブサマリー
・序論
・市場トレンド分析
・ファイブフォース分析
・人乳オリゴ糖の世界市場:製品別(シアリルラクトース(6’SL)、シアリルラクトース(3’SL)、ラクト-N-テトラオース(LNT)、ラクト-N-ネオテトラオース(LNnT)、フコシルラクトース(3’FL))
・人乳オリゴ糖の世界市場:用途別(機能性食品および飲料、栄養補助食品、幼児用フォーミュラ、人間と動物の健康成分、その他)
・人乳オリゴ糖の世界市場:地域別
・主要動向
・企業概要
【レポートの概要】

According to Stratistics MRC, the Global Human Milk Oligosaccharides Market is accounted for $17.90 million in 2018 and is expected to reach $98.05 million by 2027 growing at a CAGR of 21%. Growing application of HMOs in functional foods and increasing demand in infant formula is likely to boost the growth of the market. However, the high cost of production is hindering the growth of the global human milk oligosaccharides market is likely to hamper the profit boundaries.

Human milk oligosaccharides (HMOs) act as prebiotics in human body and help in maintaining gut health. They promote bacterial growth, especially bifidobacteria genus, in the gut, which helps in improving metabolic activity. The antimicrobial protection and prebiotic functions of the product allow them to be used in various food products including pharmaceutical and medicinal food and infant formulas.

Based on the application, the infant formulas are anticipated to grow at the fastest rate during the forecast period. This is attributable to the health benefits associated with the infant formulas such as maintaining gut microbiota and inhibition of pathogen in infants.

By geography, North America recorded the largest share of the global human milk oligosaccharides market revenues. The presence of several major infant formula and baby food manufacturers and technological advancements in the region can be considered major factors driving the market growth.

Some of the key players in the Human Milk Oligosaccharides Market include ZuChem Inc, Medolac Laboratories, Jennewein Biotechnologie GmbH, Inbiose NV, Glycosyn LLC, Glycom A/S and Elicityl S A.

Products Covered:
• Sialyllactose (6’SL)
• Sialyllactose (3’SL)
• Lacto-N-tetraose (LNT)
• Lacto-N-neotetraose (LNnT)
• Fucosyllactose (3’FL)
• Fucosyllactose (2’FL)

Applications Covered:
• Functional Food & Beverages
• Food Supplements
• Infant Formula
• Health Ingredients for Human and Animal
• Other applications

Regions Covered:
• North America
US
Canada
Mexico
• Europe
Germany
UK
Italy
France
Spain
Rest of Europe
• Asia Pacific
Japan
China
India
Australia
New Zealand
South Korea
Rest of Asia Pacific
• South America
Argentina
Brazil
Chile
Rest of South America
• Middle East & Africa
Saudi Arabia
UAE
Qatar
South Africa
Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2017, 2018, 2019, 2023 and 2027
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic analysis: Drivers and Constraints, Product/Technology Analysis, Porter’s five forces analysis, SWOT analysis etc.
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
Comprehensive profiling of additional market players (up to 3)
SWOT Analysis of key players (up to 3)
• Regional Segmentation
Market estimations, Forecasts and CAGR of any prominent country as per the clients interest (Note: Depends of feasibility check)
• Competitive Benchmarking
Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

【レポートの目次】

1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Application Analysis
3.8 Emerging Markets
3.9 Futuristic Market Scenario
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Human Milk Oligosaccharides Market, By Product
5.1 Introduction
5.2 Sialyllactose (6’SL)
5.3 Sialyllactose (3’SL)
5.4 Lacto-N-tetraose (LNT)
5.5 Lacto-N-neotetraose (LNnT)
5.6 Fucosyllactose (3’FL)
5.7 Fucosyllactose (2’FL)
6 Global Human Milk Oligosaccharides Market, By Applications
6.1 Introduction
6.2 Functional Food & Beverages
6.3 Food Supplements
6.4 Infant Formula
6.5 Health Ingredients for Human and Animal
6.6 Other Applications
7 Global Human Milk Oligosaccharides Market, By Geography
7.1 Introduction
7.2 North America
7.2.1 US
7.2.2 Canada
7.2.3 Mexico
7.3 Europe
7.3.1 Germany
7.3.2 UK
7.3.3 Italy
7.3.4 France
7.3.5 Spain
7.3.6 Rest of Europe
7.4 Asia Pacific
7.4.1 Japan
7.4.2 China
7.4.3 India
7.4.4 Australia
7.4.5 New Zealand
7.4.6 South Korea
7.4.7 Rest of Asia Pacific
7.5 South America
7.5.1 Argentina
7.5.2 Brazil
7.5.3 Chile
7.5.4 Rest of South America
7.6 Middle East & Africa
7.6.1 Saudi Arabia
7.6.2 UAE
7.6.3 Qatar
7.6.4 South Africa
7.6.5 Rest of Middle East & Africa
8 Key Developments
8.1 Agreements, Partnerships, Collaborations and Joint Ventures
8.2 Acquisitions & Mergers
8.3 New Product Launch
8.4 Expansions
8.5 Other Key Strategies
9 Company Profiling
9.1 ZuChem Inc
9.2 Medolac Laboratories
9.3 Jennewein Biotechnologie GmbH
9.4 Inbiose NV
9.5 Glycosyn LLC
9.6 Glycom A/S
9.7 Elicityl S A
List of Tables
Table 1 Global Human Milk Oligosaccharides Market Outlook, By Region (2017-2027) ($MN)
Table 2 Global Human Milk Oligosaccharides Market Outlook, By Product (2017-2027) ($MN)
Table 3 Global Human Milk Oligosaccharides Market Outlook, By Sialyllactose (6’SL) (2017-2027) ($MN)
Table 4 Global Human Milk Oligosaccharides Market Outlook, By Sialyllactose (3’SL) (2017-2027) ($MN)
Table 5 Global Human Milk Oligosaccharides Market Outlook, By Lacto-N-tetraose (LNT) (2017-2027) ($MN)
Table 6 Global Human Milk Oligosaccharides Market Outlook, By Lacto-N-neotetraose (LNnT) (2017-2027) ($MN)
Table 7 Global Human Milk Oligosaccharides Market Outlook, By Fucosyllactose (3’FL) (2017-2027) ($MN)
Table 8 Global Human Milk Oligosaccharides Market Outlook, By Fucosyllactose (2’FL) (2017-2027) ($MN)
Table 9 Global Human Milk Oligosaccharides Market Outlook, By Applications (2017-2027) ($MN)
Table 10 Global Human Milk Oligosaccharides Market Outlook, By Functional Food & Beverages (2017-2027) ($MN)
Table 11 Global Human Milk Oligosaccharides Market Outlook, By Food Supplements (2017-2027) ($MN)
Table 12 Global Human Milk Oligosaccharides Market Outlook, By Infant Formula (2017-2027) ($MN)
Table 13 Global Human Milk Oligosaccharides Market Outlook, By Health Ingredients for Human and Animal (2017-2027) ($MN)
Table 14 Global Human Milk Oligosaccharides Market Outlook, By Other applications (2017-2027) ($MN)
Table 15 North America Human Milk Oligosaccharides Market Outlook, By Country (2017-2027) ($MN)
Table 16 North America Human Milk Oligosaccharides Market Outlook, By Product (2017-2027) ($MN)
Table 17 North America Human Milk Oligosaccharides Market Outlook, By Sialyllactose (6’SL) (2017-2027) ($MN)
Table 18 North America Human Milk Oligosaccharides Market Outlook, By Sialyllactose (3’SL) (2017-2027) ($MN)
Table 19 North America Human Milk Oligosaccharides Market Outlook, By Lacto-N-tetraose (LNT) (2017-2027) ($MN)
Table 20 North America Human Milk Oligosaccharides Market Outlook, By Lacto-N-neotetraose (LNnT) (2017-2027) ($MN)
Table 21 North America Human Milk Oligosaccharides Market Outlook, By Fucosyllactose (3’FL) (2017-2027) ($MN)
Table 22 North America Human Milk Oligosaccharides Market Outlook, By Fucosyllactose (2’FL) (2017-2027) ($MN)
Table 23 North America Human Milk Oligosaccharides Market Outlook, By Applications (2017-2027) ($MN)
Table 24 North America Human Milk Oligosaccharides Market Outlook, By Functional Food & Beverages (2017-2027) ($MN)
Table 25 North America Human Milk Oligosaccharides Market Outlook, By Food Supplements (2017-2027) ($MN)
Table 26 North America Human Milk Oligosaccharides Market Outlook, By Infant Formula (2017-2027) ($MN)
Table 27 North America Human Milk Oligosaccharides Market Outlook, By Health Ingredients for Human and Animal (2017-2027) ($MN)
Table 28 North America Human Milk Oligosaccharides Market Outlook, By Other applications (2017-2027) ($MN)
Table 29 Europe Human Milk Oligosaccharides Market Outlook, By Country (2017-2027) ($MN)
Table 30 Europe Human Milk Oligosaccharides Market Outlook, By Product (2017-2027) ($MN)
Table 31 Europe Human Milk Oligosaccharides Market Outlook, By Sialyllactose (6’SL) (2017-2027) ($MN)
Table 32 Europe Human Milk Oligosaccharides Market Outlook, By Sialyllactose (3’SL) (2017-2027) ($MN)
Table 33 Europe Human Milk Oligosaccharides Market Outlook, By Lacto-N-tetraose (LNT) (2017-2027) ($MN)
Table 34 Europe Human Milk Oligosaccharides Market Outlook, By Lacto-N-neotetraose (LNnT) (2017-2027) ($MN)
Table 35 Europe Human Milk Oligosaccharides Market Outlook, By Fucosyllactose (3’FL) (2017-2027) ($MN)
Table 36 Europe Human Milk Oligosaccharides Market Outlook, By Fucosyllactose (2’FL) (2017-2027) ($MN)
Table 37 Europe Human Milk Oligosaccharides Market Outlook, By Applications (2017-2027) ($MN)
Table 38 Europe Human Milk Oligosaccharides Market Outlook, By Functional Food & Beverages (2017-2027) ($MN)
Table 39 Europe Human Milk Oligosaccharides Market Outlook, By Food Supplements (2017-2027) ($MN)
Table 40 Europe Human Milk Oligosaccharides Market Outlook, By Infant Formula (2017-2027) ($MN)
Table 41 Europe Human Milk Oligosaccharides Market Outlook, By Health Ingredients for Human and Animal (2017-2027) ($MN)
Table 42 Europe Human Milk Oligosaccharides Market Outlook, By Other applications (2017-2027) ($MN)
Table 43 Asia Pacific Human Milk Oligosaccharides Market Outlook, By Country (2017-2027) ($MN)
Table 44 Asia Pacific Human Milk Oligosaccharides Market Outlook, By Product (2017-2027) ($MN)
Table 45 Asia Pacific Human Milk Oligosaccharides Market Outlook, By Sialyllactose (6’SL) (2017-2027) ($MN)
Table 46 Asia Pacific Human Milk Oligosaccharides Market Outlook, By Sialyllactose (3’SL) (2017-2027) ($MN)
Table 47 Asia Pacific Human Milk Oligosaccharides Market Outlook, By Lacto-N-tetraose (LNT) (2017-2027) ($MN)
Table 48 Asia Pacific Human Milk Oligosaccharides Market Outlook, By Lacto-N-neotetraose (LNnT) (2017-2027) ($MN)
Table 49 Asia Pacific Human Milk Oligosaccharides Market Outlook, By Fucosyllactose (3’FL) (2017-2027) ($MN)
Table 50 Asia Pacific Human Milk Oligosaccharides Market Outlook, By Fucosyllactose (2’FL) (2017-2027) ($MN)
Table 51 Asia Pacific Human Milk Oligosaccharides Market Outlook, By Applications (2017-2027) ($MN)
Table 52 Asia Pacific Human Milk Oligosaccharides Market Outlook, By Functional Food & Beverages (2017-2027) ($MN)
Table 53 Asia Pacific Human Milk Oligosaccharides Market Outlook, By Food Supplements (2017-2027) ($MN)
Table 54 Asia Pacific Human Milk Oligosaccharides Market Outlook, By Infant Formula (2017-2027) ($MN)
Table 55 Asia Pacific Human Milk Oligosaccharides Market Outlook, By Health Ingredients for Human and Animal (2017-2027) ($MN)
Table 56 Asia Pacific Human Milk Oligosaccharides Market Outlook, By Other applications (2017-2027) ($MN)
Table 57 South America Human Milk Oligosaccharides Market Outlook, By Country (2017-2027) ($MN)
Table 58 South America Human Milk Oligosaccharides Market Outlook, By Product (2017-2027) ($MN)
Table 59 South America Human Milk Oligosaccharides Market Outlook, By Sialyllactose (6’SL) (2017-2027) ($MN)
Table 60 South America Human Milk Oligosaccharides Market Outlook, By Sialyllactose (3’SL) (2017-2027) ($MN)
Table 61 South America Human Milk Oligosaccharides Market Outlook, By Lacto-N-tetraose (LNT) (2017-2027) ($MN)
Table 62 South America Human Milk Oligosaccharides Market Outlook, By Lacto-N-neotetraose (LNnT) (2017-2027) ($MN)
Table 63 South America Human Milk Oligosaccharides Market Outlook, By Fucosyllactose (3’FL) (2017-2027) ($MN)
Table 64 South America Human Milk Oligosaccharides Market Outlook, By Fucosyllactose (2’FL) (2017-2027) ($MN)
Table 65 South America Human Milk Oligosaccharides Market Outlook, By Applications (2017-2027) ($MN)
Table 66 South America Human Milk Oligosaccharides Market Outlook, By Functional Food & Beverages (2017-2027) ($MN)
Table 67 South America Human Milk Oligosaccharides Market Outlook, By Food Supplements (2017-2027) ($MN)
Table 68 South America Human Milk Oligosaccharides Market Outlook, By Infant Formula (2017-2027) ($MN)
Table 69 South America Human Milk Oligosaccharides Market Outlook, By Health Ingredients for Human and Animal (2017-2027) ($MN)
Table 70 South America Human Milk Oligosaccharides Market Outlook, By Other applications (2017-2027) ($MN)
Table 71 Middle East & Africa Human Milk Oligosaccharides Market Outlook, By Country (2017-2027) ($MN)
Table 72 Middle East & Africa Human Milk Oligosaccharides Market Outlook, By Product (2017-2027) ($MN)
Table 73 Middle East & Africa Human Milk Oligosaccharides Market Outlook, By Sialyllactose (6’SL) (2017-2027) ($MN)
Table 74 Middle East & Africa Human Milk Oligosaccharides Market Outlook, By Sialyllactose (3’SL) (2017-2027) ($MN)
Table 75 Middle East & Africa Human Milk Oligosaccharides Market Outlook, By Lacto-N-tetraose (LNT) (2017-2027) ($MN)
Table 76 Middle East & Africa Human Milk Oligosaccharides Market Outlook, By Lacto-N-neotetraose (LNnT) (2017-2027) ($MN)
Table 77 Middle East & Africa Human Milk Oligosaccharides Market Outlook, By Fucosyllactose (3’FL) (2017-2027) ($MN)
Table 78 Middle East & Africa Human Milk Oligosaccharides Market Outlook, By Fucosyllactose (2’FL) (2017-2027) ($MN)
Table 79 Middle East & Africa Human Milk Oligosaccharides Market Outlook, By Applications (2017-2027) ($MN)
Table 80 Middle East & Africa Human Milk Oligosaccharides Market Outlook, By Functional Food & Beverages (2017-2027) ($MN)
Table 81 Middle East & Africa Human Milk Oligosaccharides Market Outlook, By Food Supplements (2017-2027) ($MN)
Table 82 Middle East & Africa Human Milk Oligosaccharides Market Outlook, By Infant Formula (2017-2027) ($MN)
Table 83 Middle East & Africa Human Milk Oligosaccharides Market Outlook, By Health Ingredients for Human and Animal (2017-2027) ($MN)
Table 84 Middle East & Africa Human Milk Oligosaccharides Market Outlook, By Other applications (2017-2027) ($MN)



【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の人乳オリゴ糖市場見通し2018-2027(Human Milk Oligosaccharides - Global Market Outlook (2018-2027))]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆